The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease-Reference-Cited by-同舟云学术

The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease

Published:2006-02 Issue:1 Volume:29 Page:112-118
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:J Inherit Metab Dis

Author:

Kalliokoski R. J.,Kantola I.,Kalliokoski K. K.,Engblom E.,Sundell J.,Hannukainen J. C.,Janatuinen T.,Raitakari O. T.,Knuuti J.,Penttinen M.,Viikari J.,Nuutila P.

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

http://www.springerlink.com/index/pdf/10.1007/s10545-006-0221-3

Reference36 articles.

1. Alenius S, Ruotsalainen U, Astola J (1998) Using local median as the location of the prior distribution in iterative emission tomography image reconstruction. IEEE Trans Nuclr Sci 45: 3097–3104.

2. Altarescu G, Moore DF, Pursley R, et al (2001) Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke 32: 1559–1562.

3. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L (1967) Enzymatic defect in Fabry’s disease. Ceramidetrihexosidase deficiency. N Engl J Med 276: 1163–1167.

4. Baehner F, Kampmann C, Whybra C, Miebach E, Wiethoff CM, Beck M (2003) Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study. J Inherit Metab Dis 26: 617–627.

5. Beck M, Ricci R, Widmer U, et al (2004) Fabry disease: overall effects of agalsidase alfa treatment. Eur J Clin Invest 34: 838–844.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impairment of sympathetic activity in Fabry disease cardiomyopathy: A further challenge for cardiac imaging;Journal of Nuclear Cardiology;2023-10

2. Coronary microvascular disease in hypertrophic and infiltrative cardiomyopathies;Journal of Nuclear Cardiology;2022-08-01

3. Fabry Disease Cardiomyopathy: A Review of the Role of Cardiac Imaging from Diagnosis to Treatment;Reviews in Cardiovascular Medicine;2022-05-27

4. Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes;Journal of Clinical Medicine;2022-02-07

5. Fabry Disease and the Effectiveness of Enzyme Replacement Therapy (ERT) in Left Ventricular Hypertrophy (LVH) Improvement: A Review and Meta-Analysis;International Journal of Medical Sciences;2022